American Bio Medica's Rapid Drug Screen Approved by the Mexican Ministry of Transportation.HUDSON, N.Y.--(BUSINESS WIRE)--Oct. 19, 1998-- -- Local Distributor Generates Increased Sales, Including Recent Shipment to the Mexican Ministry of Justice -- American Bio Medica medica (māˑ·dē·k Corporation (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :ABMC ABMC American Battle Monuments Commission ABMC Alexian Brothers Medical Center (Illinois) ABMC Aviation Battle Management Concept ABMC Arrowbear Music Camp (California) ) today announced that the Mexican Ministry of Transportation has certified that the Company's Rapid Drug Screen(tm) on-site test for drugs of abuse is accurate and can be used as a qualitative on-site drug screen. The certification follows a rigorous scientific study which was conducted by the Ministry's toxicology laboratory. The Company said that the laboratory's medical director is reporting results of the study in a Latin American scientific publication. "Sales from Mexico have been increasing steadily due to our distributor's aggressive and successful efforts in both the governmental and corporate drug testing sectors," stated ABMC Managing Director of International Business John Huss. "We are honored by the Ministry of Transportation's certification which further confirms the accuracy and reliability of our uniquely easy-to-use on-site tests." The Company's Rapid Drug Screen was originally approved and registered for sale in Mexico by the country's Ministry of Health in September 1997. Shortly thereafter, the Company appointed its Mexican distributor Laborotorios DEVOR, S.A. de C.V. which has been working with several government ministries, the state of Jalisco, and a number of commercial customers. The Company also reported that it recently shipped a significant order of the Rapid Drug Screen to its Mexican distributor for use by the country's Ministry of Justice. Laborotorios DEVOR, S.A. de C.V. is located in Guadalajara and has offices in Mexico City Mexico City Spanish Ciudad de México City (pop., 2000: city, 8,605,239; 2003 metro. area est., 18,660,000), capital of Mexico. Located at an elevation of 7,350 ft (2,240 m), it is officially coterminous with the Federal District, which occupies 571 sq mi and Monterey. American Bio Medica Corporation develops, manufactures, and markets inexpensive, accurate, on-site drugs of abuse diagnostic kits and support services support services Psychology Non-health care-related ancillary services–eg, transportation, financial aid, support groups, homemaker services, respite services, and other services worldwide. The Company's global distributors target the workplace, clinical, rehabilitation rehabilitation: see physical therapy. , physicians, corrections, and educational markets. ABMC's Rapid Drug Screen(a) is proven to correlate 100% with the standard laboratory screening test. Forward-looking statements in this release are made pursuant to the "safe harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. " provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Investors are cautioned that such forward-looking statements involve risk and uncertainties, including without limitation, continued acceptance of the Company's products, increased levels of competition for the Company, new products and technological changes, the Company's dependence on third-party suppliers, intellectual property rights, and other risks detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion